Focused Ultrasound Ablation Inc.

HIFU uses the EDAP Ablatherm HiFU system, which was cleared by the FDA in November of 2015. The first HiFU treatments were performed in 1993. Advantages of treatment via the Ablatherm include a robotically controlled treatment administered by factory trained urologists certified by the world's most renowned physicians thereby yielding consistently excellent results. It has fewer compromising side effects common to cancer treatments, e.g., surgery, cryosurgery and radiation. In addition, it has been demonstrated that HiFU treatment results in meaningful preservation of quality of life for the patient. 

Ablatherm HiFU has been used in more than 250 centers around the world with beneficial results in more than 100,000 cases. It is typically recommended for patients with localized prostate cancer and want a minimally invasive option with low side effects.  Why take chances under prostate urology maintenance – HiFU is low risk, has a high success rate and may be covered by your insurance – Let HiFU provide you with a new beginning.